Probiotics, prebiotics, and synbiotics: Gut and beyond

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Vyas, Usha ^a   Ranganathan, Natarajan ^a  

^a Newtown Business Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INULIN; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; TACROLIMUS; WARFARIN;

ALLERGY; ATOPY; AUTISM; AUTOIMMUNE DISEASE; BIFIDOBACTERIUM; BIOINFORMATICS; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLON CANCER; DRUG SAFETY; DYSLIPIDEMIA; FAMILIAL MEDITERRANEAN FEVER; GASTROINTESTINAL DISEASE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE; INTESTINE FLORA; LACTOBACILLUS; METAGENOMICS; MICROBIOME; MICROFLORA; NONHUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH CANCER;

EID: 84867349985     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/872716     Document Type: Review

References (173)

1. Kunz C., Kuntz S., Rudloff S., Intestinal flora. Advances in Experimental Medicine and Biology 2009 639 67 79 2-s2.0-62749154624 10.1007/978-1-4020-8749- 36
2. Morelli L., Postnatal development of intestinal microflora as influenced by infant nutrition. Journal of Nutrition 2008 138 supplement 9 S1791 S1795 2-s2.0-51049108796
3. Neish A. S., Microbes in gastrointestinal health and disease. Gastroenterology 2009 136 1 65 80 2-s2.0-59849113547 10.1053/j.gastro.2008.10. 080
4. Ley R. E., Peterson D. A., Gordon J. I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006 124 4 837 848 2-s2.0-32944466887 10.1016/j.cell.2006.02.017
5. Savage D. C., Associations of indigenous microorganisms with gastrointestinal mucosal epithelia. American Journal of Clinical Nutrition 1970 23 11 1495 1501 2-s2.0-0014884226
6. Whitman W. B., Coleman D. C., Wiebe W. J., Prokaryotes: the unseen majority. Proceedings of the National Academy of Sciences of the United States of America 1998 95 12 6578 6583 2-s2.0-0032499758 10.1073/pnas.95.12.6578
7. Chiller K., Selkin B. A., Murakawa G. J., Skin microflora and bacterial infections of the skin. Journal of Investigative Dermatology Symposium Proceedings 2001 6 3 170 174 2-s2.0-0035756147
8. Hull M. W., Chow A. W., Indigenous microflora and innate immunity of the head and neck. Infectious Disease Clinics of North America 2007 21 2 265 282 2-s2.0-34249876626 10.1016/j.idc.2007.03.015
9. Verstraelen H., Cutting edge: the vaginal microflora and bacterial vaginosis. Verhandelingen 2008 70 3 147 174 2-s2.0-49649092913
10. Williams N. T., Probiotics. American Journal of Health-System Pharmacy 2010 67 6 449 458 2-s2.0-77949619014 10.2146/ajhp090168
11. Dominguez-Bello M. G., Costello E. K., Contreras M., Magris M., Hidalgo G., Fierer N., Knight R., Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proceedings of the National Academy of Sciences of the United States of America 2010 107 26 11971 11975 2-s2.0-77955386857 10.1073/pnas.1002601107
12. Zoetendal E. G., Akkermans A. D. L., De Vos W. M., Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Applied and Environmental Microbiology 1998 64 10 3854 3859 2-s2.0-0031684010
13. Mariat D., Firmesse O., Levenez F., Guimares V. D., Sokol H., Doré J., Corthier G., Furet J. P., The firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiology 2009 9, article 123 2-s2.0-67651151152 10.1186/1471-2180-9-123
14. Kleessen B., Blaut M., Modulation of gut mucosal biofilms. British Journal of Nutrition 2005 93 S35 S40 2-s2.0-23044509165 10.1079/BJN20041346
15. Hamer H. M., Jonkers D., Venema K., Vanhoutvin S., Troost F. J., Brummer R. J., Review article: the role of butyrate on colonic function. Alimentary Pharmacology and Therapeutics 2008 27 2 104 119 2-s2.0-37149022209 10.1111/j.1365-2036.2007.03562.x
16. Salminen S., Bouley C., Boutron-Ruault M. C., Cummings J. H., Franck A., Gibson G. R., Isolauri E., Moreau M. C., Roberfroid M., Rowland I., Functional food science and gastrointestinal physiology and function. British Journal of Nutrition 1998 80 1 S147 S171 2-s2.0-2342660790
17. Stappenbeck T. S., Hooper L. V., Gordon J. I., Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15451 15455 2-s2.0-0037180433 10.1073/pnas.202604299
18. Lefebvre P., Cariou B., Lien F., Kuipers F., Staels B., Role of bile acids and bile acid receptors in metabolic regulation. Physiological Reviews 2009 89 1 147 191 2-s2.0-58249110568 10.1152/physrev.00010.2008
19. Wong J. M. W., de Souza R., Kendall C. W. C., Emam A., Jenkins D. J. A., Colonic health: fermentation and short chain fatty acids. Journal of Clinical Gastroenterology 2006 40 3 235 243 2-s2.0-33748209543 10.1097/00004836- 200603000-00015
20. Tlaskova-Hogenova H., Stepankova R., Hudcovic T., Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters 2004 93 97 108
21. Round J. L., Mazmanian S. K., The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology 2009 9 5 313 323 2-s2.0-67349250428 10.1038/nri2515
22. Haverson K., Rehakova Z., Sinkora J., Sver L., Bailey M., Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: a study in germ-free pigs. Veterinary Immunology and Immunopathology 2007 119 3-4 243 253 2-s2.0-34548428699 10.1016/j.vetimm.2007.05.022
23. Hapfelmeier S., Lawson M. A. E., Slack E., Kirundi J. K., Stoel M., Heikenwalder M., Cahenzli J., Velykoredko Y., Balmer M. L., Endt K., Geuking M. B., Curtiss R., McCoy K. D., Macpherson A. J., Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010 328 5986 1705 1709 2-s2.0-77954051526 10.1126/science.1188454
24. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G., Yamasaki S., Saito T., Ohba Y., Taniguchi T., Takeda K., Hori S., Ivanov I. I., Umesaki Y., Itoh K., Honda K., Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011 331 6015 337 341 2-s2.0-78650667577 10.1126/science.1198469
25. Mazmanian S. K., Cui H. L., Tzianabos A. O., Kasper D. L., An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005 122 1 107 118 2-s2.0-22144490199 10.1016/j.cell.2005. 05.007
26. Ivanov I. I., Atarashi K., Manel N., Brodie E. L., Shima T., Karaoz U., Wei D., Goldfarb K. C., Santee C. A., Lynch S. V., Tanoue T., Imaoka A., Itoh K., Takeda K., Umesaki Y., Honda K., Littman D. R., Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009 139 3 485 498 2-s2.0-70350343544 10.1016/j.cell.2009.09.033
27. Lührs H., Gerke T., Müller J. G., Melcher R., Schauber J., Boxberger F., Scheppach W., Menzel T., Butyrate inhibits NF- κ B activation in lamina propria macrophages of patients with ulcerative colitis. Scandinavian Journal of Gastroenterology 2002 37 4 458 466 2-s2.0-0036212170 10.1080/003655202317316105
28. Maslowski K. M., Vieira A. T., Ng A., Kranich J., Sierro F., Di Yu, Schilter H. C., Rolph M. S., MacKay F., Artis D., Xavier R. J., Teixeira M. M., MacKay C. R., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009 461 7268 1282 1286 2-s2.0-70350666634 10.1038/nature08530
29. Strauch U. G., Obermeier F., Grunwald N., Gürster S., Dunger N., Schultz M., Griese D. P., Mähler M., Schölmerich J., Rath H. C., Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 2005 54 11 1546 1552 2-s2.0-27444440273 10.1136/gut.2004.059451
30. Honda K., Takeda K., Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunology 2009 2 3 187 196 2-s2.0-65449124271 10.1038/mi.2009.8
31. Sartor R. B., Microbial influences in inflammatory bowel diseases. Gastroenterology 2008 134 2 577 594 2-s2.0-38649115342 10.1053/j.gastro.2007.11. 059
32. Lee B. J., Bak Y.-T., Irritable bowel syndrome, gut microbiota and probiotics. Journal of Neurogastroenterology and Motility 2011 17 3 252 256
33. Hofer U., Speck R. F., Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Seminars in Immunopathology 2009 31 2 257 266 2-s2.0-70349273714 10.1007/s00281-009-0158-3
34. Liu C. H., Yang X. Q., Liu C. H., He Y., Wang L. J., Allergic airway response associated with the intestinal microflora disruption induced by antibiotic therapy. Zhonghua Er Ke Za Zhi 2007 45 6 450 454 2-s2.0-53649085208
35. Penders J., Stobberingh E. E., Brandt P. A. V. D., Thijs C., The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007 62 11 1223 1236 2-s2.0-35148856682 10.1111/j.1398-9995.2007.01462.x
36. Verhulst S. L., Vael C., Beunckens C., Nelen V., Goossens H., Desager K., A longitudinal analysis on the association between antibiotic use, intestinal microflora, and wheezing during the first year of life. Journal of Asthma 2008 45 9 828 832 2-s2.0-55249118914 10.1080/02770900802339734
37. Food and Agriculture Organization, World Health Organization, Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria 2001
38. Gibson G. R., Scott K. P., Rastall R. A., Dietary prebiotics: current status and new definition. Food Science and Technology Bulletin 2010 7 1 1 19
39. World Gastroenterology Organization Global Guidelines,. October 2011
40. Cani P. D., Delzenne N. M., The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design 2009 15 13 1546 1558 2-s2.0-67650604595 10.2174/138161209788168164
41. Cani P. D., Delzenne N. M., Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Current Opinion in Pharmacology 2009 9 6 737 743 2-s2.0-70449574399 10.1016/j.coph.2009.06.016
42. Larsen N., Vogensen F. K., Van Den Berg F. W. J., Nielsen D. S., Andreasen A. S., Pedersen B. K., Al-Soud W. A., Sorensen S. J., Hansen L. H., Jakobsen M., Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010 5 2 2-s2.0-77949393654 10.1371/journal.pone. 0009085 e9085
43. Furet J. P., Kong L. C., Tap J., Poitou C., Basdevant A., Bouillot J. L., Mariat D., Corthier G., Doré J., Henegar C., Rizkalla S., Clément K., Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010 59 12 3049 3057 2-s2.0-78650037263 10.2337/db10-0253
44. Ley R. E., Obesity and the human microbiome. Current Opinion in Gastroenterology 2010 26 1 5 11 2-s2.0-74249119678 10.1097/MOG.0b013e328333d751
45. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N. A., Donus C., Hardt P. D., Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010 18 1 190 195 2-s2.0-73949137604 10.1038/oby.2009.167
46. Wu X., Ma C., Han L., Nawaz M., Gao F., Zhang X., Yu P., Zhao C., Li L., Zhou A., Wang J., Moore J. E., Cherie Millar B., Xu J., Molecular characterisation of the faecal microbiota in patients with type II diabetes. Current Microbiology 2010 61 1 69 78 2-s2.0-77953650911 10.1007/s00284-010-9582- 9
47. Dewulf E. M., Cani P. D., Neyrinck A. M., Possemiers S., Holle A. V., Muccioli G. G., Deldicque L., Bindels L. B., Pachikian B. D., Sohet F. M., Mignolet E., Francaux M., Larondelle Y., Delzenne N. M., Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPAR γ -related adipogenesis in the white adipose tissue of high-fat diet-fed mice. Journal of Nutritional Biochemistry 2011 22 8 712 722 2-s2.0-79960299449 10.1016/j.jnutbio.2010.05.009
48. Cani P. D., Neyrinck A. M., Fava F., Knauf C., Burcelin R. G., Tuohy K. M., Gibson G. R., Delzenne N. M., Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007 50 11 2374 2383 2-s2.0-34848912627 10.1007/s00125-007-0791-0
49. Cani P. D., Possemiers S., Van De Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D. M., Muccioli G. G., Delzenne N. M., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009 58 8 1091 1103 2-s2.0-65249099918 10.1136/gut.2008.165886
50. Aronsson L., Huang Y., Parini P., Korach-André M., Håkansson J., Gustafsson J. Å., Pettersson S., Arulampalam V., Rafter J., Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS ONE 2010 5 9 2-s2.0-77958615207 10.1371/journal.pone.0013087 e13087
51. Andreasen A. S., Larsen N., Pedersen-Skovsgaard T., Berg R. M. G., Mller K., Svendsen K. D., Jakobsen M., Pedersen B. K., Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. British Journal of Nutrition 2010 104 12 1831 1838 2-s2.0-78650011778 10.1017/S0007114510002874
52. Kadooka Y., Sato M., Imaizumi K., Ogawa A., Ikuyama K., Akai Y., Okano M., Kagoshima M., Tsuchida T., Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 2010 64 6 636 643 2-s2.0-77953230366 10.1038/ejcn.2010.19
53. Lu Z. X., Walker K. Z., Muir J. G., O'Dea K., Arabinoxylan fibre improves metabolic control in people with type II diabetes. European Journal of Clinical Nutrition 2004 58 4 621 628 2-s2.0-16544382398 10.1038/sj.ejcn.1601857
54. Garcia A. L., Steiniger J., Reich S. C., Weickert M. O., Harsch I., Machowetz A., Mohlig M., Spranger J., Rudovich N. N., Meuser F., Doerfer J., Katz N., Speth M., Zunft H. J. F., Pfeiffer A. H. F., Koebnick C., Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance. Hormone and Metabolic Research 2006 38 11 761 766 2-s2.0-33845353653 10.1055/s-2006-955089
55. Garcia A. L., Otto B., Reich S. C., Weickert M. O., Steiniger J., Machowetz A., Rudovich N. N., Möhlig M., Katz N., Speth M., Meuser F., Doerfer J., Zunft H. J. F., Pfeiffer A. H. F., Koebnick C., Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. European Journal of Clinical Nutrition 2007 61 3 334 341 2-s2.0-33847687249 10.1038/sj.ejcn. 1602525
56. Parnell J. A., Reimer R. A., Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. American Journal of Clinical Nutrition 2009 89 6 1751 1759 2-s2.0-66849129539 10.3945/ajcn.2009.27465
57. Luo J., Van Yperselle M., Rizkalla S. W., Rossi F., Bornet F. R., Slama G., Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. Journal of Nutrition 2000 130 6 1572 1577 2-s2.0-0343183296
58. Daubioul C. A., Horsmans Y., Lambert P., Danse E., Delzenne N. M., Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. European Journal of Clinical Nutrition 2005 59 5 723 726 2-s2.0-19144365839 10.1038/sj.ejcn.1602127
59. Musso G., Gambino R., Cassader M., Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annual Review of Medicine 2011 62 361 380 2-s2.0-79551577263 10.1146/annurev-med-012510-175505
60. Prussin C., Metcalfe D. D., IgE, mast cells, basophils, and eosinophils. Journal of Allergy and Clinical Immunology 2003 111 supplement 2 S486 S494 2-s2.0-0037323482
61. Cookson W., Genetics and genomics of asthma and allergic diseases. Immunological Reviews 2002 190 195 206 2-s2.0-0036951192 10.1034/j.1600-065X. 2002.19015.x
62. Steinke J. W., Borish L., Rosenwasser L. J., Genetics of hypersensitivity. Journal of Allergy and Clinical Immunology 2003 111 supplement 2 S495 S501 2-s2.0-0037326165
63. Larsen F. S., Hanifin J. M., Epidemiology of atopic dermatitis. Immunology and Allergy Clinics of North America 2002 22 1 1 24 2-s2.0-0036172724 10.1016/S0889-8561(03)00066-3
64. Björkstén B., Naaber P., Sepp E., Mikelsaar M., The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clinical and Experimental Allergy 1999 29 3 342 346 2-s2.0-0033041388 10.1046/j.1365-2222.1999.00560.x
65. Sepp E., Julge K., Vasar M., Naaber P., Björksten B., Mikelsaar M., Intestinal microflora of Estonian and Swedish infants. Acta Paediatrica 1997 86 9 956 961 2-s2.0-0030851665
66. Kalliomäki M., Salminen S., Arvilommi H., Kero P., Koskinen P., Isolauri E., Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 2001 357 9262 1076 1079 2-s2.0-0035820307 10.1016/S0140-6736(00)04259-8
67. Majamaa H., Isolauri E., Probiotics: a novel approach in the management of food allergy. Journal of Allergy and Clinical Immunology 1997 99 2 179 185 2-s2.0-0031041742 10.1016/S0091-6749(97)70093-9
68. Rosenfeldt V., Benfeldt E., Nielsen S. D., Michaelsen K. F., Jeppesen D. L., Valerius N. H., Paerregaard A., Effect of probiotic Lactobacillus strains in children with atopic dermatitis. Journal of Allergy and Clinical Immunology 2003 111 2 389 395 2-s2.0-0037327049
69. Weston S., Halbert A., Richmond P., Prescott S. L., Effects of probiotics on atopic dermatitis: a randomised controlled trial. Archives of Disease in Childhood 2005 90 9 892 897 2-s2.0-20444475470 10.1136/adc.2004.060673
70. Wickens K., Black P. N., Stanley T. V., Mitchell E., Fitzharris P., Tannock G. W., Purdie G., Crane J., A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology 2008 122 4 788 794 2-s2.0-53049095486 10.1016/j.jaci.2008.07.011
71. Niers L., Martín R., Rijkers G., Sengers F., Timmerman H., Van Uden N., Smidt H., Kimpen J., Hoekstra M., The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009 64 9 1349 1358 2-s2.0-68949207372 10.1111/j.1398-9995.2009.02021.x
72. Gobel R., Larsen N., Molgaard C., Jakobsen M., Michaelsen K. F., Probiotics to young children with atopic dermatitis: a randomized placebo-controlled trial. International Journal of Probiotics and Prebiotics 2010 5 2 53 60
73. Rosenfeldt V., Benfeldt E., Valerius N. H., Pærregaard A., Michaelsen K. F., Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. Journal of Pediatrics 2004 145 5 612 616 2-s2.0-7444248463 10.1016/j.jpeds.2004.06.068
74. Williams R., Review article: bacterial flora and pathogenesis in hepatic encephalopathy. Alimentary Pharmacology and Therapeutics 2007 25 supplement 1 17 22 2-s2.0-33846436400 10.1111/j.1746-6342.2006.03217.x
75. Gibson G. R., Wang X., Regulatory effects of bifidobacteria on the growth of other colonic bacteria. Journal of Applied Bacteriology 1994 77 4 412 420 2-s2.0-0027996351
76. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., Doyle J., Jewell L., De Simone C., Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001 121 3 580 591 2-s2.0-0034831139
77. Yurdaydin C., Walsh T. J., Engler H. D., Ha J. H., Li Y., Jones E. A., Basile A. S., Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy. Brain Research 1995 679 1 42 48 2-s2.0-0028956902 10.1016/0006-8993(95)00241-H
78. Malaguarnera M., Greco F., Barone G., Gargante M. P., Malaguarnera M., Toscano M. A., Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Digestive Diseases and Sciences 2007 52 11 3259 3265 2-s2.0-34848832109 10.1007/s10620-006-9687-y
79. Zhao H. Y., Wang H. J., Lu Z., Xu S. Z., Intestinal microflora in patients with liver cirrhosis. Chinese Journal of Digestive Diseases 2004 5 2 64 67 2-s2.0-2342640188 10.1111/j.1443-9573.2004.00157.x
80. Liu Q., Duan Z. P., Ha D. K., Bengmark S., Kurtovic J., Riordan S. M., Synbiotic modulation of gut flora: effect of minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004 39 5 1441 1449 2-s2.0-2342580955 10.1002/hep.20194
81. McGee R. G., Bakens A., Wiley K., Riordan S. M., Webster A. C., Probiotics for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2011 9 11 CD008716
82. Abd El-Gawad I. A., El-Sayed E. M., Hafez S. A., El-Zeini H. M., Saleh F. A., The hypocholesterolaemic effect of milk yoghurt and soy-yoghurt containing bifidobacteria in rats fed on a cholesterol-enriched diet. International Dairy Journal 2005 15 1 37 44 2-s2.0-8844233577 10.1016/j.idairyj.2004.06.001
83. Nguyen T. D. T., Kang J. H., Lee M. S., Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. International Journal of Food Microbiology 2007 113 3 358 361 2-s2.0-33846291771 10.1016/j.ijfoodmicro.2006.08.015
84. Fukushima M., Yamada A., Endo T., Nakano M., Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on δ 6-desaturase activity in the livers of rats fed a fat- and cholesterol-enriched diet. Nutrition 1999 15 5 373 378 2-s2.0-0032968906 10.1016/S0899-9007(99)00030- 1
85. Anderson J. W., Gilliland S. E., Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. Journal of the American College of Nutrition 1999 18 1 43 50 2-s2.0-0033024518
86. Xiao J. Z., Kondo S., Takahashi N., Miyaji K., Oshida K., Hiramatsu A., Iwatsuki K., Kokubo S., Hosono A., Effects of milk products fermented by B longum on blood lipids in rats and healthy adult male volunteers. Journal of Dairy Science 2003 86 7 2452 2461 2-s2.0-0141609047
87. Trautwein E. A., Rieckhoff D., Erbersdobler H. F., Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. Journal of Nutrition 1998 128 11 1937 1943 2-s2.0-0031769934
88. Hsu C. K., Liao J. W., Chung Y. C., Hsieh C. P., Chan Y. C., Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. Journal of Nutrition 2004 134 6 1523 1528 2-s2.0-2642560470
89. Causey J. L., Feirtag J. M., Gallaher D. D., Tungland B. C., Slavin J. L., Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutrition Research 2000 20 2 191 201 2-s2.0-0034141989 10.1016/S0271-5317(99)00152-9
90. Liong M. T., Dunshea F. R., Shah N. P., Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high- and low-fat diets. British Journal of Nutrition 2007 98 4 736 744 2-s2.0-34748922305 10.1017/ S0007114507747803
91. Kieling G., Schneider J., Jahreis G., Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. European Journal of Clinical Nutrition 2002 56 9 843 849 2-s2.0-0036739647 10.1038/sj.ejcn.1601399
92. Schaafsma G., Meuling W. J. A., Van Dokkum W., Bouley C., Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. European Journal of Clinical Nutrition 1998 52 6 436 440 2-s2.0-0031748473
93. Hatakka K., Mutanen M., Holma R., Saxelin M., Korpela R., L rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids. Journal of the American College of Nutrition 2008 27 4 441 447 2-s2.0-58749100326
94. Simons L. A., Amansec S. G., Conway P., Effect of L fermentum on serum lipids in subjects with elevated serum cholesterol. Nutrition, Metabolism and Cardiovascular Diseases 2006 16 8 531 535 2-s2.0-33751189183 10.1016/j.numecd.2005.10.009
95. Lewis S. J., Burmeister S., A double-blind placebo-controlled study of the effects of L acidophilus on plasma lipids. European Journal of Clinical Nutrition 2005 59 6 776 780 2-s2.0-21244483147 10.1038/sj.ejcn.1602139
96. Tarpila S., Aro A., Salminen I., Tarpila A., Kleemola P., Akkila J., Adlercreutz H., The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone. European Journal of Clinical Nutrition 2002 56 2 157 165 2-s2.0-0036170316 10.1038/sj/ejcn/1601298
97. Davidson M. H., Maki K. C., Synecki C., Torri S. A., Drennan K. B., Effects of dietary inulin on serum lipids in men and women with hypercholesterolemia. Nutrition Research 1998 18 3 503 517 2-s2.0-0032030967 10.1016/S0271-5317(98)00038-4
98. Greany K. A., Bonorden M. J. L., Hamilton-Reeves J. M., McMullen M. H., Wangen K. E., Phipps W. R., Feirtag J., Thomas W., Kurzer M. S., Probiotic capsules do not lower plasma lipids in young women and men. European Journal of Clinical Nutrition 2008 62 2 232 237 2-s2.0-39049172654 10.1038/sj.ejcn.1602719
99. Aso Y., Akaza H., Kotake T., Tsukamoto T., Imai K., Naito S., Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. European Urology 1995 27 2 104 109 2-s2.0-0028900687
100. Klinder A., Förster A., Caderni G., Femia A. P., Pool-Zobel B. L., Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutrition and Cancer 2004 49 2 144 155 2-s2.0-8444238512
101. Bolognani F., Rumney C. J., Pool-Zobel B. L., Rowland I. R., Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. European Journal of Nutrition 2001 40 6 293 300 2-s2.0-0035711224 10.1007/s394-001-8359-7
102. Pool-Zobel B., Van Loo J., Rowland I., Roberfroid M. B., Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer. British Journal of Nutrition 2002 87 supplement 2 S273 S281 2-s2.0-0036288062
103. Roller M., Caderni G., Rechkemmer G., Watzl B., Long term treatment with a prebiotic modulates the gut-associated immune system of azomethane-treated F344 rats. Proceedings of the SKLM Symposium Functional Food: Safety Aspects May 2002 Karlsruhe, Germany 5 7
104. Verghese M., Rao D. R., Chawan C. B., Williams L. L., Shackelford L., Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at the promotion stage in young Fisher 344 rats. Journal of Nutrition 2002 132 9 2809 2813 2-s2.0-0036715257
105. Taper H. S., Roberfroid M. B., Inulin/oligofructose and anticancer therapy. British Journal of Nutrition 2002 87 supplement 2 S283 S286 2-s2.0-0036085195
106. Femia A. P., Luceri C., Dolara P., Giannini A., Biggeri A., Salvadori M., Clune Y., Collins K. J., Paglierani M., Caderni G., Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002 23 11 1953 1960 2-s2.0-0036849544
107. Rafter J., Bennett M., Caderni G., Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. American Journal of Clinical Nutrition 2007 85 2 488 496 2-s2.0-33846878508
108. Aso Y., Akaza H., Kotake T., Tsukamoto T., Imai K., Naito S., Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. European Urology 1995 27 2 104 109
109. Ohashi Y., Nakai S., Tsukamoto T., Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urologia Internationalis 2002 68 4 273 280 2-s2.0-0036016972 10.1159/000058450
110. Okawa T., Niibe H., Arai T., Effect of LC9018 combined with radiation therapy on carcinoma of the uterine cervix: a phase III, multicenter, randomized, controlled study. Cancer 1993 72 6 1949 1954 2-s2.0-0027219785
111. Liu Z., Qin H., Yang Z., Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgerya double-blind study. 2011 33 1 50 63 2-s2.0-78649987442 10.1111/j.1365-2036.2010.04492.x
112. Chitapanarux I., Chitapanarux T., Traisathit P., Kudumpee S., Tharavichitkul E., Lorvidhaya V., Randomized controlled trial of live Lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiation Oncology 2010 5 1, article 31 2-s2.0-77951800189 10.1186/1748-717X-5-31
113. Delia P., Sansotta G., Donato V., Use of probiotics for prevention of radiation-induced diarrhea. World Journal of Gastroenterology 2007 13 6 912 915 2-s2.0-34249908112
114. Österlund P., Ruotsalainen T., Korpela R., Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. British Journal of Cancer 2007 97 8 1028 1034 2-s2.0-35348904439 10.1038/sj.bjc.6603990
115. Prakash S., Chang T. M. S., Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nature Medicine 1996 2 8 883 887 2-s2.0-0029847820 10.1038/nm0896-883
116. Ranganathan N., Patel B., Ranganathan P., Marczely J., Dheer R., Chordia T., Dunn S. R., Friedman E. A., Probiotic amelioration of azotemia in 5/6th nephrectomized Sprague-Dawley rats. TheScientificWorldJournal 2005 5 652 660 2-s2.0-33644889971
117. Ranganathan N., Patel B., Ranganathan P., Marczely J., Dheer R., Chordia T., Yang Z., Friedman E. A., Probiotics reduces azotemia in gottingen mini-pigs. Proceedings of the 3rd World Congress of Nephrology Poster Presentation June 2005 Singapore
118. Palmquist R., A preliminary clinical evaluation of kibow biotics, a probiotic agent, on feline azotemia. Journal of the American Holistic Medical Association 2006 24 4 23 27
119. Simenhoff M. L., Dunn S. R., Zollner G. P., Fitzpatrick M. E. D., Emery S. M., Sandine W. E., Ayres J. W., Biomodulation of the toxic and nutritional effects of small bowel overgrowth in end stage kidney disease using freeze dried L acidophilus. Mineral and Electrolyte Metabolism 1996 22 13 92 96 2-s2.0-0029656038
120. Dunn S. R., Simenhoff M. L., Ahmed K. E., Gaughan W. J., Eltayeb B. O., Fitzpatrick M. E. D., Emery S. M., Ayres J. W., Holt K. E., Effect of oral administration of freeze-dried Lactobacillus acidophilus on small bowel bacterial overgrowth in patients with end stage kidney disease: reducing uremic toxins and improving nutrition. International Dairy Journal 1998 8 5-6 545 553 2-s2.0-0032075971 10.1016/S0958-6946(98)00081-8
121. Altermann E., Russell W. M., Azcarate-Peril M. A., Barrangou R., Buck B. L., McAuliffe O., Souther N., Dobson A., Duong T., Callanan M., Lick S., Hamrick A., Cano R., Klaenhammer T. R., Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proceedings of the National Academy of Sciences of the United States of America 2005 102 11 3906 3912 2-s2.0-17644389315 10.1073/pnas.0409188102
122. Ranganathan N., Friedman E. A., Tam P., Rao V., Ranganathan P., Dheer R., Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Current Medical Research and Opinion 2009 25 8 1919 1930 2-s2.0-67650812006 10.1185/03007990903069249
123. Ranganathan N., Ranganathan P., Friedman E. A., Joseph A., Delano B., Goldfarb D. S., Tam P., Venketeshwer Rao A., Anteyi E., Guido Musso C., Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Advances in Therapy 2010 27 9 634 647 2-s2.0-77956218438 10.1007/s12325-010-0059-9
124. Loscalzo J., Lipid metabolism by gut microbes and atherosclerosis. Circulation Research 2011 109 2 127 129 2-s2.0-79960365932 10.1161/RES. 0b013e3182290620
125. Wang Z., Klipfell E., Bennett B. J., Koeth R., Levison B. S., Dugar B., Feldstein A. E., Britt E. B., Fu X., Chung Y. M., Wu Y., Schauer P., Smith J. D., Allayee H., Tang W. H. W., Didonato J. A., Lusis A. J., Hazen S. L., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011 472 7341 57 63 2-s2.0-79953733693 10.1038/nature09922
126. Oxman T., Shapira M., Klein R., Avazov N., Rabinowitz B., Oral administration of Lactobacillus induces cardioprotection. Journal of Alternative and Complementary Medicine 2001 7 4 345 354 2-s2.0-0034840214
127. De Roos N. M., Katan M. B., Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988
128. Naruszewicz M., Johansson M. L., Zapolska-Downar D., Bukowska H., Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. American Journal of Clinical Nutrition 2002 76 6 1249 1255 2-s2.0-18744378321
129. Lam V., Su J., Koprowski S., Hsu A., Tweddell J. S., Rafiee P., Gross G. J., Salzman N. H., Baker J. E., Intestinal microbiota determine severity of myocardial infarction in rats. The FASEB Journal 2012 26 4 1727 1735 2-s2.0-84860909327 10.1096/fj.11-197921
130. Gershon M. D., The Second Brain: the Scientific Basis of Gut Instinct and a Groundbreaking New Understanding of Nervous Disorders of the Stomach and Intestines 1998 New York, NY, USA HarperCollins
131. Macpherson A. J., Slack E., The functional interactions of commensal bacteria with intestinal secretory IgA. Current Opinion in Gastroenterology 2007 23 6 673 678 2-s2.0-34848861840 10.1097/MOG.0b013e3282f0d012
132. Goehler L. E., Gaykema R. P. A., Nguyen K. T., Lee J. E., Tilders F. J. H., Maier S. F., Watkins L. R., Interleukin-1 β in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? Journal of Neuroscience 1999 19 7 2799 2806 2-s2.0-0033106495
133. Hosoi J., Murphy G. F., Egan C. L., Lerner E. A., Grabbe S., Asahina A., Granstein R. D., Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993 363 6425 159 163 2-s2.0-0027314249 10.1038/363159a0
134. Borovikova L. V., Ivanova S., Zhang M., Yang H., Botchkina G. I., Watkins L. R., Wang H., Abumrad N., Eaton J. W., Tracey K. J., Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000 405 6785 458 462 2-s2.0-0034713266 10.1038/35013070
135. Ghia J. E., Blennerhassett P., Kumar-Ondiveeran H., Verdu E. F., Collins S. M., The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006 131 4 1122 1130 2-s2.0-33749321161 10.1053/j.gastro.2006.08.016
136. Lyte M., Freestone P. P. E., Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health 2010 New York, NY, USA Springer
137. Lyte M., Microbial endocrinology and infectious disease in the 21st century. Trends in Microbiology 2004 12 1 14 20 2-s2.0-0347360213 10.1016/j.tim.2003.11.004
138. Lyte M., The role of microbial endocrinology in infectious disease. Journal of Endocrinology 1993 137 3 343 345 2-s2.0-0027219094
139. Everest P., Stress and bacteria: microbial endocrinology. Gut 2007 56 8 1037 1038 2-s2.0-34547236011 10.1136/gut.2006.117150
140. Roshchina V. V., Lyte M., Freestone P. P. E., Evolutionary considerations of neurotransmitters in microbial, plant and animal cells. Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health 2010 New York, NY, USA Springer 17 52
141. Iyer L. M., Aravind L., Coon S. L., Klein D. C., Koonin E. V., Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role? Trends in Genetics 2004 20 7 292 299 2-s2.0-2942709486 10.1016/j.tig.2004.05.007
142. Lyte M., Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. BioEssays 2011 33 8 574 581 2-s2.0-79960464084 10.1002/bies. 201100024
143. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T. G., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. Journal of Psychiatric Research 2008 43 2 164 174 2-s2.0-53049087266 10.1016/j.jpsychires.2008.03.009
144. Bercik P., Verdú E. F., Foster J. A., Lu J., Scharringa A., Kean I., Wang L., Blennerhassett P., Collins S. M., Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. American Journal of Physiology 2009 296 3 R587 R594 2-s2.0-64149126241 10.1152/ajpregu.90752.2008
145. Zareie M., Johnson-Henry K., Jury J., Yang P. C., Ngan B. Y., McKay D. M., Soderholm J. D., Perdue M. H., Sherman P. M., Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006 55 11 1553 1560 2-s2.0-33750364231 10.1136/gut.2005.080739
146. Eutamene H., Lamine F., Chabo C., Theodorou V., Rochat F., Bergonzelli G. E., Corthésy-Theulaz I., Fioramonti J., Bueno L., Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. Journal of Nutrition 2007 137 8 1901 1907 2-s2.0-34548107027
147. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., Bisson J. F., Rougeot C., Pichelin M., Cazaubiel M., Cazaubiel J. M., Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. The British Journal of Nutrition 2011 105 5 755 764 2-s2.0-79953160733 10.1017/S0007114510004319
148. Gruenwald J., Graubaum H. J., Harde A., Effect of a probiotic multivitamin compound on stress and exhaustion. Advances in Therapy 2002 19 3 141 150 2-s2.0-0036562878
149. Rao A. V., Bested A. C., Beaune T. M., Katzman M. A., Iorio C., Berardi J. M., Logan A. C., A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens 2009 1, article 6
150. Khachatryan Z. A., Ktsoyan Z. A., Manukyan G. P., Kelly D., Ghazaryan K. A., Aminov R. I., Predominant role of host genetics in controlling the composition of gut microbiota. PLoS ONE 2008 3 8 2-s2.0-51849086745 10.1371/journal.pone.0003064 e3064
151. Manukyan G. P., Ghazaryan K. A., Ktsoyan Z. A., Khachatryan Z. A., Arakelova K. A., Kelly D., Grant G., Aminov R. I., Elevated systemic antibodies towards commensal gut microbiota in autoinflammatory condition. PLoS ONE 2008 3 9 2-s2.0-52649091852 10.1371/journal.pone.0003172 e3172
152. Bolte E. R., Autism and clostridium tetani. Medical Hypotheses 1998 51 2 133 144 2-s2.0-0031853068
153. Finegold S. M., Molitoris D., Song Y., Liu C., Vaisanen M.-L., Bolte E., McTeague M., Sandler R., Wexler H., Marlowe E. M., Collins M. D., Lawson P. A., Summanen P., Baysallar M., Tomzynski T. J., Read E., Johnson E., Rolfe R., Nasir P., Shah H., Haake D. A., Manning P., Kaul A., Gastrointestinal microflora studies in late-onset autism. Clinical Infectious Diseases 2002 35 supplement 1 S6 S16 2-s2.0-0036061028 10.1086/341914
154. Lindh J., Possible interaction between probiotics and warfarin. Läkartidningen 2010 107 13-14, article 917
155. Greenblatt D. J., von Moltke L. L., Interaction of warfarin with drugs, natural substances, and foods. Journal of Clinical Pharmacology 2005 45 2 127 132 2-s2.0-16844373618 10.1177/0091270004271404
156. Natural Medicines Comprehensive Database,. Lactobacillus monograph
157. Natural Medicines Comprehensive Database,. Bifidobacteria monograph
158. Natural Medicines Comprehensive Database,. Saccharomyces boulardii monograph
159. Florastor (Saccharomyces boulardii lyo) Package Insert 200509 Beauvais, France Biocodex
160. Bentley R., Meganathan R., Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiological Reviews 1982 46 3 241 280 2-s2.0-0020413535
161. Resta S. C., Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. Journal of Physiology 2009 587 17 4169 4174 2-s2.0-69949087471 10.1113/jphysiol.2009.176370
162. Kindberg C., Suttie J. W., Uchida K., Hirauchi K., Nakao H., Menaquinone production and utilization in germ-free rats after inoculation with specific organisms. Journal of Nutrition 1987 117 6 1032 1035 2-s2.0-0023352871
163. Hojo K., Nagaoka S., Murata S., Taketomo N., Ohshima T., Maeda N., Reduction of vitamin K concentration by salivary Bifidobacterium strains and their possible nutritional competition with Porphyromonas gingivalis. Journal of Applied Microbiology 2007 103 5 1969 1974 2-s2.0-35448972166 10.1111/j.1365-2672.2007.03436.x
164. Ioannides C., Effect of diet and nutrition on the expression of cytochromes P450. Xenobiotica 1999 29 2 109 154 2-s2.0-0032964849
165. Schmidt L. E., Dalhoff K., Food-drug interactions. Drugs 2002 62 10 1481 1502 2-s2.0-0036073540
166. Singh B. N., Effects of food on clinical pharmacokinetics. Clinical Pharmacokinetics 1999 37 3 213 255 2-s2.0-0032883045 10.2165/00003088-199937030- 00003
167. Harris R. Z., Jang G. R., Tsunoda S., Dietary effects on drug metabolism and transport. Clinical Pharmacokinetics 2003 42 13 1071 1088 2-s2.0-0242288522 10.2165/00003088-200342130-00001
168. D'Souza A. L., Rajkumar C., Cooke J., Bulpitt C. J., Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. British Medical Journal 2002 324 7350 1361 1364 2-s2.0-0037042674
169. United States Department of Health and Human Services, Evidence report/technology assessment number 200. 2011 11-E007 AHRQ
170. The Human Microbiome Project Consortium, Structure, function and diversity of the healthy human microbiome. Nature 2012 486 207 214
171. Yatsunenko T., Rey F. E., Manary M. J., Human gut microbiome viewed across age and geography. Nature 2012 486 222 228
172. Cantael B. L., Lombard V., Henrissat B., Complex carbohydrate utilization by the healthy human microbiome. PLoS One 2012 7 6 e28742
173. Li K., Bihan M., Yooseph S., Methe B. A., Analyses of the microbial diversity across the human microbiome. PLoS One 2012 7 6 e32118